1Cvitkovic E. A historical perspective on Oxaliplatin: rethinking the role of platinum compounds and learing from near misses[J]. Semin Oncol, 1998,2502 ( Suppl 57 ): 1-3
2Bleiberg H. Oxaliplatin (L-OHP): a new reality in colorectal cancer[J]. Br J cancer,1998,77 (Suppl 4): 1-3.
3Becouarin Y, Rongier P . Clinical efficacy of Oxaliplatin monotherapy: phase Ⅱ trials in advanced colorectal cancer[ J].Semin Oncol, 1998,25 ( Suppl 5 ) :23-31.
4Beliberg H, de Granont A. Oxaliplatin plus 5-fluorouracil: clinical experience in patients with advanced colorectal cancer [ J ].Semin Oncol, 1998,2592( Suppl 5 ) :32-39.
5Ducreux M,, Louvet C, Bekradda N, et al. Oxaliplatin for the treatment of advanced colorectal cancer: future directions [ J ].Semin Oncol, 1998,25 ( Suppl 5 ) :47-53.
6Raymond E, Feivre M, Waynaroushi JM, et al. Oxaliplatin:mechanism of action and anti neoplastic activity [ J ] . Semin Oncol, 1998,25 ( Suppl 5 ) :4-12.
7Extra JM,Marty M, Brienza S,et al. Pharmacokinetics and safety profile on Oxaliplatin [ J ]. Semin Oncol, 1998,25 ( Suppl 5 ): 13-22.
8Andre T,Bensmaine MA,Louvet C,et al.Multicenter,phase Ⅱ study of bimonthly high-dose leucovorin,fluorouracil infudion,and oxaliplatin for metastatic colorectal cancer resisitant to the same leucovorin and fluorouracil regimen.J.Clin.Oncol.,1999,17(11):3560-3568.
9De Gramont A,Tournigand C,Louvet C,et al.Oxaliplatin folinicacid and 5-fluorouracil(folflox) in pretreated patients with metastatic advanced cancer[J].Rev.Med.Int,1997,18(10):769-775.
10Bismuth H,Adam R,Reduction of nonresectable liver metastasis from colorectal cancer after oxaliplatin chemotherapy[J],Semin Oncol,1998,25(2 Suppl 5):40-46.
3Tashiro AJ,Moore CW. Accu mulation of cis-diammine dichloroplatinum(Ⅱ) and platinum analogues by platinrm resistant murine leukemia cells invitro[J]. Cancer Res,1998,48(1):9-13
